Lippo Cikarang Tbk PT
IDX:LPCK
Lippo Cikarang Tbk PT
IDX:LPCK
Price:
735
IDR
-2.65%
Market Closed
Market Cap:
2T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
LPCK Alert
Lippo Cikarang Tbk PT
735
-20 (-2.65%)
| 52 Week Range |
484
850
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Lippo Cikarang Tbk PT
Balance Sheet
Balance Sheet Decomposition
Lippo Cikarang Tbk PT
Lippo Cikarang Tbk PT
| Current Assets | 6.9T |
| Cash & Short-Term Investments | 275B |
| Receivables | 18.6B |
| Other Current Assets | 6.6T |
| Non-Current Assets | 2.9T |
| Long-Term Investments | 2.4T |
| PP&E | 76B |
| Other Non-Current Assets | 431.9B |
| Current Liabilities | 2.3T |
| Accounts Payable | 26B |
| Accrued Liabilities | 180B |
| Short-Term Debt | 330B |
| Other Current Liabilities | 1.8T |
| Non-Current Liabilities | 598B |
| Long-Term Debt | 130B |
| Other Non-Current Liabilities | 468B |
Balance Sheet
Lippo Cikarang Tbk PT
Lippo Cikarang Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
246 052
|
122 075
|
181 659
|
323 738
|
95 157
|
200 830
|
635 427
|
376 198
|
206 730
|
206 107
|
|
| Cash |
0
|
122 075
|
181 659
|
323 738
|
95 157
|
200 830
|
503 559
|
342 330
|
173 730
|
173 107
|
|
| Cash Equivalents |
246 052
|
0
|
0
|
0
|
0
|
0
|
131 868
|
33 868
|
33 000
|
33 000
|
|
| Short-Term Investments |
0
|
812 084
|
987 931
|
545 544
|
791 434
|
598 821
|
171 837
|
132 055
|
116 744
|
106 810
|
|
| Total Receivables |
117 758
|
209 661
|
185 285
|
248 008
|
295 251
|
266 930
|
21 189
|
26 092
|
25 461
|
21 282
|
|
| Accounts Receivables |
65 539
|
209 661
|
185 285
|
248 008
|
295 251
|
266 930
|
21 189
|
26 092
|
25 461
|
21 282
|
|
| Other Receivables |
52 219
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2 882 168
|
2 764 561
|
2 843 764
|
8 044 555
|
3 967 168
|
5 078 166
|
5 724 998
|
5 531 275
|
5 807 186
|
6 318 080
|
|
| Other Current Assets |
415 726
|
375 297
|
386 151
|
967 489
|
703 952
|
153 324
|
202 439
|
161 018
|
185 419
|
188 760
|
|
| Total Current Assets |
3 661 704
|
4 283 677
|
4 584 790
|
10 129 334
|
5 852 962
|
6 298 071
|
6 755 890
|
6 226 638
|
6 341 540
|
6 841 039
|
|
| PP&E Net |
54 301
|
80 994
|
87 631
|
99 723
|
357 183
|
184 258
|
95 347
|
82 706
|
107 941
|
79 525
|
|
| PP&E Gross |
54 301
|
80 994
|
87 631
|
99 723
|
357 183
|
184 258
|
95 347
|
82 706
|
107 941
|
79 525
|
|
| Accumulated Depreciation |
64 134
|
76 018
|
89 386
|
105 936
|
124 833
|
143 436
|
174 205
|
190 325
|
204 431
|
202 870
|
|
| Note Receivable |
9 078
|
7 053
|
23 949
|
8 785
|
411 355
|
8 908
|
15 685
|
16 481
|
15 934
|
15 721
|
|
| Long-Term Investments |
505 665
|
922 603
|
822 766
|
845 742
|
2 580 573
|
5 687 592
|
2 571 914
|
2 545 542
|
2 521 414
|
2 385 729
|
|
| Other Long-Term Assets |
79 076
|
182 430
|
134 018
|
1 371 919
|
23 549
|
40 399
|
280 734
|
263 170
|
362 784
|
359 711
|
|
| Total Assets |
4 309 824
N/A
|
5 476 757
+27%
|
5 653 153
+3%
|
12 455 503
+120%
|
9 225 622
-26%
|
12 219 228
+32%
|
9 719 570
-20%
|
9 134 537
-6%
|
9 349 613
+2%
|
9 681 725
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
40 444
|
70 309
|
29 662
|
161 501
|
272 330
|
114 230
|
84 467
|
123 442
|
62 146
|
41 548
|
|
| Accrued Liabilities |
74 272
|
90 117
|
140 993
|
254 367
|
121 139
|
172 795
|
146 652
|
313 239
|
227 994
|
183 276
|
|
| Short-Term Debt |
0
|
30 000
|
0
|
200 000
|
0
|
200 000
|
500 000
|
500 000
|
450 000
|
450 000
|
|
| Current Portion of Long-Term Debt |
20 612
|
184 498
|
167 078
|
25 245
|
233 765
|
175 873
|
71 358
|
89 208
|
120 000
|
140 000
|
|
| Other Current Liabilities |
1 394 707
|
766 072
|
584 420
|
1 102 228
|
355 256
|
287 887
|
1 355 621
|
940 792
|
1 018 698
|
1 037 950
|
|
| Total Current Liabilities |
1 530 035
|
1 140 996
|
922 152
|
1 743 341
|
982 490
|
950 785
|
2 158 098
|
1 966 681
|
1 878 838
|
1 852 774
|
|
| Long-Term Debt |
1 083
|
1 400
|
0
|
23 662
|
0
|
0
|
406 040
|
316 832
|
250 000
|
210 000
|
|
| Minority Interest |
8 250
|
38 052
|
70 682
|
74 872
|
232 961
|
312 170
|
237 587
|
31 260
|
15 179
|
42 727
|
|
| Other Liabilities |
107 247
|
701 066
|
488 309
|
2 967 084
|
713 104
|
385 921
|
576 270
|
444 078
|
525 604
|
827 625
|
|
| Total Liabilities |
1 646 615
N/A
|
1 881 514
+14%
|
1 481 144
-21%
|
4 808 959
+225%
|
1 928 555
-60%
|
1 648 876
-15%
|
3 377 995
+105%
|
2 758 851
-18%
|
2 669 621
-3%
|
2 847 672
+7%
|
|
| Equity | |||||||||||
| Common Stock |
348 000
|
348 000
|
348 000
|
348 000
|
348 000
|
1 339 800
|
1 339 800
|
1 339 800
|
1 339 800
|
1 339 800
|
|
| Retained Earnings |
2 275 752
|
3 189 948
|
3 729 337
|
4 092 749
|
4 867 154
|
5 171 888
|
974 906
|
1 028 583
|
1 341 041
|
1 499 992
|
|
| Additional Paid In Capital |
39 458
|
39 458
|
41 458
|
41 458
|
12 158
|
1 981 185
|
1 981 185
|
1 981 185
|
1 981 185
|
1 981 185
|
|
| Other Equity |
0
|
17 838
|
53 215
|
3 164 337
|
2 069 755
|
2 077 479
|
2 045 684
|
2 026 118
|
2 017 966
|
2 013 076
|
|
| Total Equity |
2 663 209
N/A
|
3 595 243
+35%
|
4 172 009
+16%
|
7 646 544
+83%
|
7 297 067
-5%
|
10 570 352
+45%
|
6 341 575
-40%
|
6 375 686
+1%
|
6 679 992
+5%
|
6 834 053
+2%
|
|
| Total Liabilities & Equity |
4 309 824
N/A
|
5 476 757
+27%
|
5 653 153
+3%
|
12 455 503
+120%
|
9 225 622
-26%
|
12 219 228
+32%
|
9 719 570
-20%
|
9 134 537
-6%
|
9 349 613
+2%
|
9 681 725
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
725
|
725
|
725
|
725
|
725
|
2 680
|
2 680
|
2 680
|
2 680
|
2 680
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
